Literature DB >> 25544289

Hypertension in Egypt: a systematic review.

Doaa M Hasan, Aya H Emeash, Sara B Mustafa, Galal Eldin A Abdelazim, Aya Alaa El-din.   

Abstract

BACKGROUND: With 29% of the world’s adult population projected to have hypertension by the year 2025, prevention and management of hypertension have become a public health priority. Hypertension also referred to as high blood pressure, in which the arteries have persistent high blood pressure. This results in a condition where the heart has to work harder than normal to flow blood through the vessels. A few years ago, there was no sufficient information about the epidemiology of hypertension, treatment protocols and its consequences in Egypt. Lately, there has been a major change in health system in Egypt, including research development.
OBJECTIVES: To evaluate the existing data on prevalence, levels of awareness, treatment and control of hypertension in Egypt with a view of suggestive actions that could enhance control of hypertension and improve quality of life of the patients.
METHODS: Six databases (Pub Med, Cochrane, MEDLINE, Sciencedirect, MedEase, Embase) were searched in November 2013, applying the following criteria: published from January 1995 to November 2013 written in English and carried out on human subjects.
RESULTS: 21 studies were included in the systematic review of the prevalence, awareness, and control of hypertension in Egypt. The sample size ranged from 27 subjects to 12008 subjects, and the age range from 6-95 years. Every study had both male and female representatives. In most of the studies, the women were more than the men.
CONCLUSION: There are declines in the levels of awareness of hypertension and even lower levels of control. Research is required to reveal reasons behind these near to the ground levels of control and treatment, and especially awareness, in order to put in the picture policy for the improvement of quality of life of hypertensive patients in Egypt.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25544289     DOI: 10.2174/1573402111666141217111807

Source DB:  PubMed          Journal:  Curr Hypertens Rev        ISSN: 1573-4021


  4 in total

1.  Understanding Non-Adherence to Treatment in Hypertension: A Qualitative Study.

Authors:  Mahnaz Ashoorkhani; Reza Majdzadeh; Jaleh Gholami; Hassan Eftekhar; Ali Bozorgi
Journal:  Int J Community Based Nurs Midwifery       Date:  2018-10

2.  Long-term safety and tolerability of valsartan in children aged 6 to 17 years with hypertension.

Authors:  Randall Lou-Meda; Brigitte Stiller; Zenaida L Antonio; Ewa Zielinska; Hui-Kim Yap; Hee Gyung Kang; Monique Tan; Robert D Glazer; Michele A Valentin; Linda Wang
Journal:  Pediatr Nephrol       Date:  2018-11-05       Impact factor: 3.714

Review 3.  A semi-systematic review on hypertension and dyslipidemia care in Egypt-highlighting evidence gaps and recommendations for better patient outcomes.

Authors:  Ashraf Reda; Hany Ragy; Kanwal Saeed; Mohammed Ashraf Alhussaini
Journal:  J Egypt Public Health Assoc       Date:  2021-12-01

4.  The effect of the mobile "blood pressure management application" on hypertension self-management enhancement: a randomized controlled trial.

Authors:  Ali Bozorgi; Hamed Hosseini; Hassan Eftekhar; Reza Majdzadeh; Ali Yoonessi; Ali Ramezankhani; Mehdi Mansouri; Mahnaz Ashoorkhani
Journal:  Trials       Date:  2021-06-24       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.